Last10K.com

Biorestorative Therapies, Inc. (BRTX) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, December 31, 2023

SEC Filings

Biorestorative Therapies, Inc.

HISTORY TOOLS
CIK: 1505497 Ticker: BRTX
Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 28, 2024
Jun. 30, 2023
Cover [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Annual Reporttrue  
Document Transition Reportfalse  
Document Period End DateDec. 31, 2023  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2023  
Current Fiscal Year End Date--12-31  
Entity File Number001-37603  
Entity Registrant NameBIORESTORATIVETHERAPIES, INC.  
Entity Central Index Key0001505497  
Entity Tax Identification Number30-1341024  
Entity Incorporation, State or Country CodeNV  
Entity Address, Address Line One40 Marcus Drive  
Entity Address, Address Line TwoSuite 1  
Entity Address, City or TownMelville  
Entity Address, State or ProvinceNY  
Entity Address, Postal Zip Code11747  
City Area Code(631)  
Local Phone Number760-8100  
Title of 12(b) SecurityCommon Stock $0.0001 par value  
Trading SymbolBRTX  
Security Exchange NameNASDAQ  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 13,663,719
Entity Bankruptcy Proceedings, Reporting Currenttrue  
Entity Common Stock, Shares Outstanding 6,769,919 
ICFR Auditor Attestation Flagfalse  
Document Financial Statement Error Correction [Flag]false  
Auditor Firm ID688  
Auditor NameMarcumLLP  
Auditor LocationMarlton,New Jersey  

View differences made from one year to another to evaluate Biorestorative Therapies, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biorestorative Therapies, Inc..

Continue

Assess how Biorestorative Therapies, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biorestorative Therapies, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Cover
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Operations
Accrued Expenses And Other Current Liabilities
Accrued Expenses And Other Current Liabilities (Tables)
Income Taxes
Income Taxes (Details Narrative)
Income Taxes (Tables)
Intangible Assets
Intangible Assets (Details Narrative)
Intangible Assets (Tables)
Leases
Leases (Details Narrative)
Leases (Tables)
Notes Payable
Notes Payable (Tables)
Organization, Liquidity And Business Operations
Organization, Liquidity And Business Operations (Details Narrative)
Property And Equipment
Property And Equipment (Details Narrative)
Property And Equipment (Tables)
Schedule Of Accrued Expenses And Other Current Liabilities (Details)
Schedule Of Fair Value Recurring Basis (Details)
Schedule Of Finite Lived Intangible Assets Amortization Expenses (Details)
Schedule Of Finite Lived Intangible Assets Future Amortization Expenses (Details)
Schedule Of Future Minimum Payments Under Non-Cancelable Leases For Operating Leases (Details)
Schedule Of Income Tax Provision (Benefit) (Details)
Schedule Of Information Related To Stock Options (Details)
Schedule Of Intangible Assets (Details)
Schedule Of Net Deferred Tax Assets And Liabilities (Details)
Schedule Of Net Lease Cost And Other Supplemental Lease Information (Details)
Schedule Of Notes Payable Activity (Details)
Schedule Of Property Plant And Equipment (Details)
Schedule Of Statutory Federal Income Tax Rate (Details)
Schedule Of Stock Option Activity (Details)
Schedule Of Stock Option Expense (Details)
Schedule Of Stock Option Granted Assumptions (Details)
Schedule Of Stock Warrants (Details)
Schedule Of Unvested Restricted Stock Units (Details)
Schedule Of Warrant Activity (Details)
Schedule Of Warrants Granted Assumptions (Details)
Schedule Of Weighted Average Dilutive Common Shares (Details)
Stockholders??? Equity
Stockholders??? Equity (Details Narrative)
Stockholders??? Equity (Tables)
Subsequent Events
Subsequent Events (Details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Ticker: BRTX
CIK: 1505497
Form Type: 10-K Annual Report
Accession Number: 0001493152-24-012056
Submitted to the SEC: Fri Mar 29 2024 6:15:33 PM EST
Accepted by the SEC: Mon Apr 01 2024
Period: Sunday, December 31, 2023
Industry: Health And Allied

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/brtx/0001493152-24-012056.htm